Escherichia coli B2 strains prevalent in inflammatory bowel disease patients have distinct metabolic capabilities that enable colonization of intestinal mucosa.
Xin FangJonathan M. MonkNathan MihBin DuAnand SastryErol S. KavvasYara SeifLarry SmarrBernhard O. PalssonPublished in: BMC Syst. Biol. (2018)
Keyphrases
- escherichia coli
- metabolic networks
- regulatory networks
- patient groups
- medical doctors
- multiple sclerosis
- early diagnosis
- cardiovascular disease
- disease progression
- metabolic pathways
- amyotrophic lateral sclerosis
- chronic disease
- systems biology
- gene regulatory networks
- computational biology
- white matter
- microarray
- gene expression data
- data sets